Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
Fortrea has signed a definitive agreement to acquire Worldwide Clinical Trials' Early Phase Services division — its Clinical Pharmacology Unit and bioanalytical laboratory operations — in an all-cash transaction valued at approximately $45M. The acquired footprint includes a 60,000 sq. ft. GLP-compliant bioanalytical lab in Austin, a 200-bed GCP-compliant clinical pharmacology unit in San Antonio, and a biospecimen storage facility in Pflugerville, Texas.
Key figures
- Deal Value Usd
- 45000000
- Acquired business
- Early Phase Services division of Worldwide Clinical Trials
- Transaction structure
- all-cash
- Bioanalytical lab sqft
- 60000
- Clinical pharmacology unit beds
- 200
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.